Answers are grounded in this paper and cite their sources.
Retrospective cohort study identifies misclassification of Saudi women’s IVF outcomes using western cut-offs, suggesting local calibrations may improve prognostic accuracy.
Background Anti-Müllerian hormone (AMH) and antral follicle count (AFC) are routinely used to stratify women undergoing in vitro fertilization (IVF), but virtually all widely cited cut-offs were derived in European or East-Asian cohorts. Women of Arabian Peninsula ancestry have AMH and AFC values 20–30% lower than these reference populations, raising concern that imported thresholds may systematically misclassify Saudi patients. We quantified this misclassification, derived locally calibrated cut-offs, and assessed clinical utility using decision-curve analysis (DCA). Methods Single-center retrospective cohort of 186 consecutive women undergoing fresh-transfer IVF on a uniform gonadotropin-releasing hormone (GnRH)-antagonist protocol at a private fertility center in Jeddah, Saudi Arabia (June–December 2024). The primary outcome was clinical pregnancy. We applied published European and European Society of Human Reproduction and Embryology (ESHRE)/Bologna thresholds to our cohort to quantify misclassification, derived locally optimal cut-offs by Youden index, and evaluated clinical utility by DCA across a range of threshold probabilities. Results The clinical pregnancy rate was 38.2% (71/186). Applying the European “good-prognosis” AMH threshold (> 3.5 ng/mL) to our cohort would have excluded approximately 53.5% of women who actually achieved clinical pregnancy from a favorable counseling category; a comparable AFC threshold (> 14) would have excluded 50.7%. Conversely, ESHRE/Bologna “poor-responder” thresholds (AMH < 1.1 ng/mL; AFC < 7) had specificity above 93% but sensitivity below 30%, providing little discrimination of poor outcomes in this population. Locally optimal cut-offs were AMH > 2.8 ng/mL (sensitivity 74.6%, specificity 73.0%) and AFC > 11 follicles (73.2%, 79.1%). On DCA, an AMH-based decision rule produced positive net benefit across plausible threshold probabilities (10–60%) while a treat-all strategy became harmful above a threshold probability (pₜ) of approximately 0.40. Conclusion Western-derived AMH and AFC thresholds materially misclassify Saudi women undergoing IVF, with up to half of women who go on to achieve clinical pregnancy falling below European “good-prognosis” cut-offs. Locally calibrated thresholds (AMH > 2.8 ng/mL; AFC > 11) better reflect this population and add net clinical benefit over default-treatment strategies on DCA. These findings should be interpreted as derivation-cohort estimates requiring multicenter external validation before clinical implementation. Because clinical pregnancy is a surrogate for live birth, these thresholds should be confirmed against cumulative live-birth rates in future work.
No takes yet. Share an insight, caveat, or question.
Mohammed Malak (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: